Studies carried out by the top American health research institute finds that Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), effectively neutralises both Alpha and Delta variants of coronavirus.
#Covaxin #BharatBiotech #Covid19
Covaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr..
Credit: IndiaTimes - Published 6 hours ago
Credit: IndiaTimes - Published 9 hours ago
SAGE members and Bharat Biotech officials will hold a meeting where safety and efficacy of Covaxin will be discussed on the basis trial data in India.
Credit: DNA - Published 4 days ago
Credit: IndiaTimes - Published 4 days ago
India's indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the World Health Organisation, eventually enabling its recipients..
Credit: DNA - Published 6 days ago